Lv31
260 积分 2024-05-10 加入
Pathological mechanisms of kidney disease in ageing
3个月前
已完结
Treatment of chronic kidney disease in older populations
3个月前
已完结
Pleiotropic effects of GLP‐1 receptor agonists on peripheral artery disease: Is there any hope?
6个月前
已完结
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
6个月前
已完结
GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region
6个月前
已完结
Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart Failure
6个月前
已完结
Recent Insights into the Roles of PEST‐Containing Nuclear Protein
1年前
已完结
Unlocking the EGFR-mediated epitranscriptome: A pathway to novel therapies
1年前
已完结
FOXM1‐mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway
1年前
已完结
Vascular complications in glioma patients
1年前
已完结
皖公网安备34019202002308
